| Literature DB >> 33664899 |
Deddy Tedjasukmana1, Kevin Triangto1, Basuni Radi2.
Abstract
Exercise for heart failure patients had been shown to be beneficial in improving functional status, and was reviewed to be safe. In cases of advanced heart failure, Cardiac Resynchronization Therapy (CRT) is a promising medical option before being a heart transplant candidate. CRT itself is a biventricular pacing device, which could detect electrical aberrance in the failing heart and provide a suitable response. Studies have shown that exercise has clear benefits toward improving an overall exercise capacity of the patients. Despite its impacts, these randomized clinical trials have varying exercise regime, and until now there has not been a standardized exercise prescription for this group of patients. The nature of CRT as a pacemaker, sometimes with defibrillator, being attached to a heart failure patient, each has its own potential exercise hazards. Therefore, providing detailed exercise prescription in adjusting to the medical condition is very essential in the field of physical medicine and rehabilitation. Being classified as a high-risk patient group, exercise challenges for the complex heart failure with CRT patients will then be discussed in this literature review, with a general aim to provide a safe, effective, and targeted exercise regime.Entities:
Keywords: aerobic exercise prescription; cardiac resynchronization therapy; functional capacity; heart failure; rehabilitation
Year: 2020 PMID: 33664899 PMCID: PMC7896451 DOI: 10.1002/joa3.12475
Source DB: PubMed Journal: J Arrhythm ISSN: 1880-4276
Comparison between safe exercise testing protocols in CRT patients , , ,
| Time (min) | CAEP | Naughton | Modified Balke | Bruce | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grade (%) | Stage (#) | Speed (mph) | Grade (%) | Stage (#) | Speed (mph) | Grade (%) | Stage (#) | Speed (mph) | Grade (%) | Stage (#) | Speed (mph) | |
| 0‐1 | 0 | 0 | 1.0 | 0 | 1 | 1.0 | 0 | 1 | 0.5 | 10 | 1 | 1.7 |
| 1‐2 | 0 | 0 | 1.0 | 0 | 1 | 1.0 | 0 | 2 | 1.0 | 10 | 1 | 1.7 |
| 2‐3 | 2 | 1 | 1.0 | 0 | 1 | 1.0 | 0 | 3 | 1.7 | 10 | 1 | 1.7 |
| 3‐4 | 2 | 1 | 1.0 | Rest | 0 | 4 | 2.2 | 12 | 2 | 2.5 | ||
| 4‐5 | 3 | 2 | 1.5 | Rest | 0 | 5 | 2.7 | 12 | 2 | 2.5 | ||
| 5‐6 | 3 | 2 | 1.5 | Rest | 0 | 6 | 3.3 | 12 | 2 | 2.5 | ||
| 6‐7 | 4 | 3 | 2.0 | 0 | 2 | 1.5 | 1 | 7 | 3.3 | 14 | 3 | 3.4 |
| 7‐8 | 4 | 3 | 2.0 | 0 | 2 | 1.5 | 2 | 8 | 3.3 | 14 | 3 | 3.4 |
| 8‐9 | 5 | 4 | 2.5 | 0 | 2 | 1.5 | 3 | 9 | 3.3 | 14 | 3 | 3.4 |
| 9‐10 | 5 | 4 | 2.5 | Rest | 4 | 10 | 3.3 | 16 | 4 | 4.2 | ||
| 10‐11 | 6 | 5 | 3.0 | Rest | 5 | 11 | 3.3 | 16 | 4 | 4.2 | ||
| 11‐12 | 6 | 5 | 3.0 | Rest | 6 | 12 | 3.3 | 16 | 4 | 4.2 | ||
| 12‐13 | 8 | 6 | 3.5 | 0 | 3 | 2.0 | 7 | 13 | 3.3 | 18 | 5 | 5.0 |
| 13‐14 | 8 | 6 | 3.5 | 0 | 3 | 2.0 | 8 | 14 | 3.3 | 18 | 5 | 5.0 |
| 14‐15 | 10 | 7 | 4.0 | 0 | 3 | 2.0 | 9 | 15 | 3.3 | 18 | 5 | 5.0 |
| 15‐16 | 10 | 7 | 4.0 | Rest | 10 | 16 | 3.3 | 20 | 6 | 5.5 | ||
| 16‐17 | 10 | 8 | 5.0 | Rest | 11 | 17 | 3.3 | 20 | 6 | 5.5 | ||
| 17‐18 | 10 | 8 | 5.0 | Rest | 12 | 18 | 3.3 | 20 | 6 | 5.5 | ||
| 18‐19 | 10 | 9 | 6.0 | 3.5 | 4 | 2.0 | 13 | 19 | 3.3 | 22 | 7 | 6.0 |
| 19‐20 | 10 | 9 | 6.0 | 3.5 | 4 | 2.0 | 14 | 20 | 3.3 | 22 | 7 | 6.0 |
| 20‐21 | 10 | 10 | 7.0 | 3.5 | 4 | 2.0 | 22 | 7 | 6.0 | |||
| 21‐22 | 10 | 10 | 7.0 | |||||||||
| 22‐23 | 15 | 11 | 7.0 | |||||||||
Summary table of various contraindications and risks to exercise testing and training
| (A) Contraindications to exercise testing & training | (B) Contraindications to exercise training | (C) Increased risk for exercise training |
|---|---|---|
| 1. Early phase after acute coronary syndrome (up to 2 days) | 1. Progressive worsening of exercise tolerance or dyspnea at rest over previous 3‐5 days | 1. >1.8 kg increase in body mass over the previous 1‐3 days |
| 2. Untreated life‐threatening cardiac arrhythmias | 2. Significant ischemia during low‐intensity exercise (<2 METs, <50 W) | 2. Concurrent, continuous, or intermittent dobutamine therapy |
| 3. Acute heart failure (during the initial period of hemodynamic instability) | 3. Uncontrolled diabetes | 3. Decrease in systolic blood pressure with exercise |
| 4. Uncontrolled hypertension | 4. Recent embolism | 4. NYHA functional class IV |
| 5. Advanced atrioventricular block | 5. Thrombophlebitis | 5. Complex ventricular arrhythmia at rest or appearing with exertion |
| 6. Acute myocarditis and pericarditis | 6. New‐onset atrial fibrillation/atrial flutter | 6. Supine resting heart rate >100 b.p.m. |
| 7. Symptomatic aortic stenosis | 7. Pre‐existing co‐morbidities limiting exercise tolerance | |
| 8. Severe hypertrophic obstructive cardiomyopathy | ||
| 9. Acute systemic illness | ||
| 10. Intracardiac thrombus |
Suggested exercise protocol in CRT patients
| CRT exercise protocol | |
|---|---|
| Frequency |
3‐5 days/week 30‐50 minutes/session |
| Intensity |
80% of Heart Rate Reserve Maximal intensity in Borg scale of 14 of 20 10‐20 beats below shock threshold for CRT‐D |
| Type |
5‐ to 10‐minute warm‐up stretches (lower extremities) 20‐ to 30‐minute aerobic ergocycle 5‐ to 10‐minute cooling down |
| Time | After 1 month medically stable preceding the implantation of CRT |
| CRT mode | Rate adaptive pacing mode |